RxDoctor Payments DataLook up a doctor →

NOVAVAX COVID-19 VACCINE, ADJUVANTED: payments to doctors

Payments that named NOVAVAX COVID-19 VACCINE, ADJUVANTED as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$484K
Providers
303
Transactions
502
Average per transaction
$964

The per-transaction average — $964 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 303 providers the average total is $1,597, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novavax Inc$483,748100.0%
← All drugs & devices